Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-09-08-Speech-4-053"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20050908.6.4-053"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:translated text |
".
Mr President, ladies and gentlemen, I would like to congratulate Mr Bowis on his report. He has identified some of the essential points on which the Commission will focus its action over the coming years with the assistance of Parliament and the Member States.
The European Commission supports the improvement of results in the field of health by means of projects, sectoral budgetary support and general budgetary support relating to results in the field of health. The Commission will also continue to support research and development with a view to preventing, treating and curing diseases, including the so-called neglected diseases. The action programme to speed up the fight against HIV/AIDS, malaria and tuberculosis in external actions, proposes supplementary actions for combating these three major diseases of poverty. The programme proposes a series of coherent and concrete actions that are often jointly managed by the European Commission and the Member States, to be undertaken both in the partner countries and at world level, with a view to strengthening the fight against these diseases and to contribute to achieving the Millennium development objectives.
Our actions must contribute to increasing the credibility of the policy of prevention, of access for treatment and of investments in the development of new vaccines and other tools and interventions for prevention or treatment. Within this context, Europe will enhance its political dialogue with its partners, with a view to helping them to confront the enormous challenges facing them by means of ambitious strategies and active participation by civil society and the private sector. Europe will contribute to strengthening the capacities of these countries in key fields, in particular regulation in the field of the evaluation and licensing of pharmaceutical products, as well as research.
I would also like to inform you of other initiatives that I have already taken and which are closely linked to the action programme. The first initiative relates to the human resources crisis in the health sector in the developing countries. As you know, this problem is critical in the countries that are trying to enhance their actions within the framework of the fight against the three diseases. I shall therefore present the College with a communication indicating the means for strengthening this fight, in cooperation with the Member States of the European Union and the African Union.
I am also going to launch a new initiative aimed at guaranteeing the availability of new medicines. This requires additional support from the World Health Organisation. It will also require new measures at European level, with a view to encouraging – as you have said very well – the private sector to invest in research and development of new medicines more specifically geared towards the curing of diseases suffered by certain countries that are clearly currently of little economic interest to the sector.
I have tried to give you a clearer idea of how the Commission intends to implement the action programme, through cooperation with the Member States of the European Union, the programming of resources and the launching of specific initiatives. I very much hope to hold a dialogue with you on these issues."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples